Comparison of disease-free survival, overall survival, and complications between patients with advanced ovarian cancer receiving neoadjuvant systemic chemotherapy with or without HIPEC

Durak D. K., TOYRAN A., Minareci Y., Sozen H., TOPUZ S., Salihoglu M. Y.

INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, cilt.36, sa.2, 2026 (SCI-Expanded, Scopus)